О. Л. Барбараш
Kemerovo State Medical University · 1,393 works · 17,235 citations · h-index 50
Top works
- Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
- Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
- Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
- Arterial hypertension in adults. Clinical guidelines 2020
- THE PREVALENCE OF NON-INFECTIOUS DISEASES RISK FACTORS IN RUSSIAN POPULATION IN 2012-2013 YEARS. THE RESULTS OF ECVD-RF
- The Changing Landscape for Stroke Prevention in AF
- Markers of calcium and phosphate metabolism and osteopenic syndrome in patients with coronary artery disease.
- Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial
- 2020 Clinical guidelines for Atrial fibrillation and atrial flutter
- Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
- RETRACTED: Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study
- Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF
- 2024 Clinical practice guidelines for Hypertension in adults
- The Influence of Low and Moderate Carotid Stenosis on Neurophysiologic Status of Patients Undergoing on-pump Coronary Artery Bypass Grafting
- Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study
- Comorbidities in clinical practice. Algorithms for diagnostics and treatment
- Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial
- Disorders of lipid metabolism. Clinical Guidelines 2023
- COMORBIDITIES IN PRACTICE. CLINICAL GUIDELINES
- Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis